Back to Vaccine Center
Disease-Vaccine Explorer
Search for a disease to find the corresponding vaccine and clinical recommendations.
Primary Indications (Diseases Covered)
- Routine childhood immunization against diphtheria, tetanus, and pertussis.
Effectiveness
Highly effective (98% for tetanus/diphtheria, 80-90% for pertussis).
Primary Indications (Diseases Covered)
- Routine childhood immunization
- Catch-up for unimmunized adults
- Outbreak control
Effectiveness
97% effective against measles after 2 doses.
Primary Indications (Diseases Covered)
- Prevention of invasive pneumococcal disease and pneumonia.
- Routine for infants, elderly, and immunocompromised.
Effectiveness
Highly effective in preventing invasive disease caused by the 20 serotypes.
Primary Indications (Diseases Covered)
- Universal infant vaccination
- Healthcare workers
- Travelers to endemic areas
- Patients on dialysis
Effectiveness
Provides >90% protection in healthy adults and >95% in infants.
Primary Indications (Diseases Covered)
- Prevention of cervical, vaginal, vulvar, anal, and oropharyngeal cancers and genital warts.
Effectiveness
Nearly 100% effective in preventing precancers caused by covered HPV types.
Primary Indications (Diseases Covered)
- Prevention of herpes zoster (shingles) and postherpetic neuralgia.
Effectiveness
>90% efficacy in preventing shingles across all age groups >= 50.
Primary Indications (Diseases Covered)
- Annual prophylaxis against seasonal influenza.
- Highly recommended for elderly, pregnant, and immunocompromised.
Effectiveness
Varies year-to-year (usually 40-60%) depending on strain match.
Primary Indications (Diseases Covered)
- Prevention of yellow fever in travelers to endemic zones in Africa/South America.
- Required for entry into certain countries (ICVP).
Effectiveness
Provides almost 100% protection, usually considered lifelong after a single dose.
Primary Indications (Diseases Covered)
- Prevention of typhoid fever for travelers to high-risk areas (South Asia, etc.).
Effectiveness
Moderate (50-80%). Lasts about 5 years.
Primary Indications (Diseases Covered)
- Prevention of severe disease, hospitalization, and death from SARS-CoV-2.
Effectiveness
Highly effective at preventing severe disease and hospitalization.